IO Biotech's Series A - II Round

IO Biotech raised a round of funding on January 04, 2017.

IO Biotech develops novel therapeutic immuno-oncology vaccines targeting immune check point inhibitory targets to treat cancer. IO Biotech is focused on unlocking the full potential of the immune syst…

Articles about IO Biotech's Series A - II Round: